200,000+ products from a single source!

sales@angenechem.com

Home > Other Building Blocks > 7327-87-9

7327-87-9

7327-87-9 | 1,4-Dihydrazinophthalazine hydrogen sulfate

CAS No: 7327-87-9 Catalog No: AG0039LT MDL No:MFCD00035271

Product Description

Catalog Number:
AG0039LT
Chemical Name:
1,4-Dihydrazinophthalazine hydrogen sulfate
CAS Number:
7327-87-9
Molecular Formula:
C8H12N6O4S
Molecular Weight:
288.2837
MDL Number:
MFCD00035271
IUPAC Name:
(4-hydrazinylphthalazin-1-yl)hydrazine;sulfuric acid
InChI:
InChI=1S/C8H10N6.H2O4S/c9-11-7-5-3-1-2-4-6(5)8(12-10)14-13-7;1-5(2,3)4/h1-4H,9-10H2,(H,11,13)(H,12,14);(H2,1,2,3,4)
InChI Key:
BWHAMWGGORIDBK-UHFFFAOYSA-N
SMILES:
OS(=O)(=O)O.NNc1nnc(c2c1cccc2)NN
EC Number:
230-808-0
UNII:
1C2B1W91NK

Properties

Complexity:
248  
Compound Is Canonicalized:
Yes
Covalently-Bonded Unit Count:
2  
Defined Atom Stereocenter Count:
0
Defined Bond Stereocenter Count:
0
Exact Mass:
288.064g/mol
Formal Charge:
0
Heavy Atom Count:
19  
Hydrogen Bond Acceptor Count:
10  
Hydrogen Bond Donor Count:
6  
Isotope Atom Count:
0
Molecular Weight:
288.282g/mol
Monoisotopic Mass:
288.064g/mol
Rotatable Bond Count:
2  
Topological Polar Surface Area:
185A^2
Undefined Atom Stereocenter Count:
0
Undefined Bond Stereocenter Count:
0

Literature

Title Journal
The differential effects of recombinant brain natriuretic peptide, nitroglycerine and dihydralazine on systemic oxygen delivery and gastric mucosal microvascular oxygenation in dogs. Anaesthesia 20120501
Long-term efficacy and tolerability of a fixed-dose combination of antihypertensive agents: an open-label surveillance study in China. Clinical drug investigation 20111101
Flow-injection chemiluminescence determination of dihydralazine sulfate in serum using luminol and diperiodatocuprate (III) system. Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy 20100101
Effects of dihydralazine on renal water and aquaporin-2 excretion in humans. Scandinavian journal of clinical and laboratory investigation 20090101
Regression of glomerulosclerosis in subtotally nephrectomized rats: effects of monotherapy with losartan, spironolactone, and their combination. American journal of physiology. Renal physiology 20080701
Chemiluminescence investigation of carbon dioxide-enhanced oxidation of dihydralazine sulfate by peroxynitrite and its application to pharmaceutical analysis. Analytica chimica acta 20080602
Maternal and fetal hemodynamic effects induced by nitric oxide donors and plasma volume expansion in pregnancies with gestational hypertension complicated by intrauterine growth restriction with absent end-diastolic flow in the umbilical artery. Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology 20080101
Progress curve analysis of CYP1A2 inhibition: a more informative approach to the assessment of mechanism-based inactivation? Drug metabolism and disposition: the biological fate of chemicals 20071201
Method development for dihydralazine with HPLC-MS/MS--an old but tricky substance in human plasma. Journal of pharmaceutical and biomedical analysis 20070117
Antihypertensive therapy in patients with pre-eclampsia: A prospective randomised multicentre study comparing dihydralazine with urapidil. European journal of obstetrics, gynecology, and reproductive biology 20060801
Dihydralazine treatment limits liver injury after hemorrhagic shock in rats. Critical care medicine 20060301
Changes in metabolism and blood flow following catecholamine stimulation in the synovial membrane measured with microdialysis. Knee surgery, sports traumatology, arthroscopy : official journal of the ESSKA 20060201
Morbidity and development in childhood of infants born after temporising treatment of early onset pre-eclampsia. BJOG : an international journal of obstetrics and gynaecology 20050701
Hypertension in children with chronic renal failure. The Turkish journal of pediatrics 20050101
Site-specific 99mTc-labeling of antibody using dihydrazinophthalazine (DHZ) conjugation to Fc region of heavy chain. Archives of pharmacal research 20040901
[Determination of five components in compound hypotensive tablet by HPLC]. Yao xue xue bao = Acta pharmaceutica Sinica 20040801
The impact of maternal plasma volume expansion and antihypertensive treatment with intravenous dihydralazine on fetal and maternal hemodynamics during pre-eclampsia: a clinical, echo-Doppler and viscometric study. Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology 20040401
Flow injection chemiluminescence determination of dihydralazine sulphate based on permanganate oxidation sensitized by rhodamine B. Luminescence : the journal of biological and chemical luminescence 20040101
[When hypertension becomes an emergency case: lower the blood pressure, but slowly!]. MMW Fortschritte der Medizin 20030529
Myocyte loss in early left ventricular hypertrophy of experimental renovascular hypertension. Virchows Archiv : an international journal of pathology 20030401
[Reversible loss of vision in severe preeclampsia: case report and review of the literature]. Zeitschrift fur Geburtshilfe und Neonatologie 20030101
Drug-induced lupus as a cause of relapsing inflammatory disease after renal transplantation. Pediatric transplantation 20020801
Immune-mediated drug-induced liver disease. Clinics in liver disease 20020801
[Effect of Urapidil in antihypertensive therapy of preeclampsia on newborns]. Zentralblatt fur Gynakologie 20010901
Influence of metabolic activation on the induction of micronuclei by antihypertensive drugs in L929 cells. Archives of toxicology 20010201
Ketanserin for the treatment of preeclampsia. Journal of perinatal medicine 20010101
Additive effects of dihydralazine during enflurane or isoflurane hypotensive anaesthesia for spinal fusion. Canadian journal of anaesthesia = Journal canadien d'anesthesie 19880501
Comparative study on the short-term effects of angiotensin converting enzyme inhibitors (Lopirin, SQUIBB and Tensiomin), and dihydralazine in chronic cardiac failure. Acta physiologica Hungarica 19880101
[Liver lesions induced by dihydralazine and propranolol]. Zentralblatt fur allgemeine Pathologie u. pathologische Anatomie 19850101
Vagally mediated bradycardiac effect of prazosin in anaesthetized rats. European journal of pharmacology 19841015
Mode of antihypertensive action of nitrendipine. Journal of cardiovascular pharmacology 19840101
Action of vasodilating drugs on small and large arteries of hypertensive patients. Journal of cardiovascular pharmacology 19830101
[Hypotensive anaesthesia in the oto-rhino-laryngological surgery using nitroglycerine (author's transl)]. Der Anaesthesist 19800501
[Rare liver damage caused by an antihypertensive and anti-arrhythmic agents]. Zeitschrift fur die gesamte innere Medizin und ihre Grenzgebiete 19800401
Effects of acute hypotension and hypertension on serum TSH concentrations in male rats. Acta physiologica Scandinavica 19791001
[Treatment of essential hypertension with a combination of propranolol, spironolactone-thiabutazide and dihydralazine (author's transl)]. Deutsche medizinische Wochenschrift (1946) 19781020

Related Products

© 2019 Angene International Limited. All rights Reserved.